| Country | Authority | Class I | Class II | Class III | Class IV | Special Considerations |
|---|---|---|---|---|---|---|
| United States | FDA | 510(k): 90d | 510(k): 90d | PMA: 180d | — | MDSAP accepted. De Novo pathway for novel low-risk devices. |
| Canada | Health Canada | 30d | 75d | 300d | 300d | MDSAP mandatory for Class II–IV. Reliance on FDA/EU decisions available. |
| Brazil | ANVISA | 60d | 60d | 365d | 365d | MDSAP accepted (reduces GMP timeline). Foreign manufacturer GMP fee BRL 72,805. |
| Mexico | COFEPRIS | 30d | 35d | 60d | — | Foreign GMP audit mandatory. |
| Argentina | ANMAT | 60d | 90d | 180d | — | MERCOSUR mutual recognition applicable. |
| Chile | ISP | 60d | 60d | 60d | — | ISP updates fees annually. |
| Colombia | INVIMA | 1 month | 1 month | 4–6 months | 4–6 months | MD Classes I/IIa vs IIb/III. INVIMA e-submission platform. |
| Ecuador | ARCSA | 30d | 60d | 90d | — | Contact ARCSA for current fee schedule. |
| Peru | DIGEMID | 7d | 30d | 90d | — | Contact DIGEMID for current fee schedule. |
| Venezuela | INHRR | 60d | 90d | 180d | — | Import license required per shipment. |
| Bolivia | AGEMED | 30d | 60d | 90d | — | Contact AGEMED for current fee schedule. |
| Paraguay | DINAVISA | 30d | 60d | 90d | — | MERCOSUR member; mutual recognition pathway available. |
| Uruguay | MSP | 30d | 60d | 90d | — | MERCOSUR member. |
| Costa Rica | MINSA | 30d | 60d | 90d | — | Contact MINSA for current fee schedule. |
| Panama | MINSA | 30d | 60d | 90d | — | Contact MINSA for current fee schedule. |
| El Salvador | MINSAL | 30d | 60d | 90d | — | Contact MINSAL for current fee schedule. |
| Guatemala | MSPAS | 30d | 60d | 90d | — | Contact MSPAS for current fee schedule. |
| Nicaragua | MINSA | 30d | 60d | 90d | — | Contact MINSA for current fee schedule. |
| Honduras | ARSA | 30d | 60d | 90d | — | Contact ARSA for current fee schedule. |
| Cuba | CECMED | 60d | 90d | 180d | — | Import restrictions; liaison agent required. |
| Jamaica | MOH Jamaica | — | — | — | — | Contact MOH Jamaica for current fee schedule. |
| Puerto Rico | FDA (US) | 510(k): 90d | 510(k): 90d | PMA: 180d | — | US FDA rules apply as a US territory. |
| Country | Authority | Class I/II (Small) | Class I/II (Large) | Class III/IV | Renewal Fee | Special Considerations |
|---|---|---|---|---|---|---|
| United States | FDA | $19,870 (510k) | $19,870 (510k) | $441,547 (PMA) | Annual estab. reg. | MDSAP accepted. |
| Canada | Health Canada | C$330 (I) / C$4,905 (II) | C$4,905 | C$15,695 | 5-yr renewal | MDSAP mandatory Class II–IV. |
| Brazil | ANVISA | BRL 1,952 (small) | BRL 1,952 (small) | BRL 8,500+ | 10-yr renewal | GMP fee: BRL 72,805 (foreign). |
| Mexico | COFEPRIS | MXN 15,896 | MXN 23,314 | MXN 29,673 | MXN 11,922–22,255 | Foreign GMP audit mandatory. |
| Argentina | ANMAT | — | — | — | 5-yr renewal | Contact ANMAT for current fee schedule. |
| Chile | ISP | CLP 190,432 | CLP 190,432 | CLP 190,432 | Per ISP schedule | Conformity verification: CLP 3,368,543. |
| Colombia | INVIMA | COP 3,898,330 | COP 3,898,330 | COP 4,412,400 | 10-yr renewal | INVIMA e-submission platform. |
| Ecuador | ARCSA | — | — | — | 5-yr renewal | Contact ARCSA for current fee schedule. |
| Peru | DIGEMID | — | — | — | 5-yr renewal | Contact DIGEMID for current fee schedule. |
| Venezuela | INHRR | — | — | — | 5-yr renewal | Contact INHRR for current fee schedule. |
| Bolivia | AGEMED | — | — | — | 5-yr renewal | Contact AGEMED for current fee schedule. |
| Paraguay | DINAVISA | — | — | — | 5-yr renewal | Contact DINAVISA for current fee schedule. |
| Uruguay | MSP | — | — | — | 5-yr renewal | Contact MSP for current fee schedule. |
| Costa Rica | MINSA | — | — | — | 5-yr renewal | Contact MINSA for current fee schedule. |
| Panama | MINSA | — | — | — | 5-yr renewal | Contact MINSA for current fee schedule. |
| El Salvador | MINSAL | — | — | — | 5-yr renewal | Contact MINSAL for current fee schedule. |
| Guatemala | MSPAS | — | — | — | 5-yr renewal | Contact MSPAS for current fee schedule. |
| Nicaragua | MINSA | — | — | — | 5-yr renewal | Contact MINSA for current fee schedule. |
| Honduras | ARSA | — | — | — | 5-yr renewal | Contact ARSA for current fee schedule. |
| Cuba | CECMED | — | — | — | 5-yr renewal | Contact CECMED for current fee schedule. |
| Jamaica | MOH Jamaica | — | — | — | Not published | Contact MOH Jamaica for current fee schedule. |
| Puerto Rico | FDA (US) | $19,870 (510k) | $19,870 (510k) | $441,547 (PMA) | Annual estab. reg. | US FDA rules apply. |
| Country | Authority | Establishment / GMP License Fee |
|---|---|---|
| United States | FDA | FDA Establishment Registration: $9,280/yr |
| Canada | Health Canada | No separate establishment fee |
| Brazil | ANVISA | AFE: BRL 1,952–19,524; GMP: BRL 2,659–72,805 |
| Mexico | COFEPRIS | Foreign GMP inspection: MXN 126,070 |
| Argentina | ANMAT | Contact ANMAT |
| Chile | ISP | Warehouse license: CLP 1,048,089 |
| Colombia | INVIMA | GMP certification: COP 2,569,000+ |
| Ecuador | ARCSA | Contact authority |
| Peru | DIGEMID | Contact authority |
| Venezuela | INHRR | Contact authority |
| Bolivia | AGEMED | Contact authority |
| Paraguay | DINAVISA | Contact authority |
| Uruguay | MSP | Contact authority |
| Costa Rica | MINSA | Contact authority |
| Panama | MINSA | Contact authority |
| El Salvador | MINSAL | Contact authority |
| Guatemala | MSPAS | Contact authority |
| Nicaragua | MINSA | Contact authority |
| Honduras | ARSA | Contact authority |
| Cuba | CECMED | Contact authority |
| Jamaica | MOH Jamaica | Contact authority |
| Puerto Rico | FDA (US) | FDA Establishment Registration: $9,280/yr |
| Country | Authority | Class I | Class II | Class III | Class IV | Special Considerations |
|---|---|---|---|---|---|---|
| United Kingdom | MHRA | No premarket review | Notified Body review | Notified Body review | — | Post-Brexit UKCA required. CE MDR not accepted from Jul 2025. |
| Germany | BfArM / DIMDI | Self-declaration | Notified Body review | Notified Body review | — | EU MDR 2017/745 applies. EUDAMED registration mandatory. |
| France | ANSM | Self-declaration | Notified Body review | Notified Body review | — | EU MDR applies. EUDAMED registration mandatory. |
| Spain | AEMPS | Self-declaration | Notified Body review | Notified Body review | — | EU MDR applies. Spanish national registry required. |
| Netherlands | CIBG / IGJ | Self-declaration | Notified Body review | Notified Body review | — | EU MDR applies. EUDAMED registration mandatory. |
| Belgium | FAMHP | Self-declaration | Notified Body review | Notified Body review | — | EU MDR applies. Clinical trial (Class I–II): €12,847. |
| Austria | BASG | Self-declaration | Notified Body review | Notified Body review | — | EU MDR applies. Small-company exemption available. |
| Switzerland | Swissmedic | CHRN registration | Notified Body review | Notified Body review | — | Swiss MedDO (TDG) aligned with EU MDR. Register within 3 months. |
| Sweden | MPA | Self-declaration | Notified Body review | Notified Body review | — | EU MDR applies. Clinical trial fee charged by MPA. |
| Finland | Fimea | Self-declaration | Notified Body review | Notified Body review | — | EU MDR applies. Inspection fee for authorized reps/importers. |
| Ireland | HPRA | Self-declaration | Notified Body review | Notified Body review | — | EU MDR applies. EUDAMED registration mandatory. |
| Iceland | Lyfjastofnun | CE mark accepted | CE mark accepted | CE mark accepted | — | EEA member; EU MDR applies. |
| Portugal | INFARMED | Self-declaration | Notified Body review | Notified Body review | — | EU MDR applies. Fee: 0.4% of monthly sales via SRCT Portal. |
| Greece | EOF | Self-declaration | Notified Body review | Notified Body review | — | EU MDR applies. Class I fee tiered by product count. |
| Romania | ANMDMR | Self-declaration | Notified Body review | Notified Body review | — | EU MDR applies. FSC: RON 1,446 (1–10 items). |
| Slovakia | ŠÚKL | Self-declaration (free) | Notified Body review | Notified Body review | — | EU MDR applies. Tech-doc assessment €845. |
| Estonia | SAM | Self-declaration | Notified Body review | Notified Body review | — | EU MDR applies. Paid services per SAM decree. |
| Latvia | ZVA | Self-declaration | Notified Body review | Notified Body review | — | EU MDR applies. Annual vigilance fee per manufacturer/AR/distributor. |
| Croatia | HALMED | Self-declaration | Notified Body review | Notified Body review | — | EU MDR applies. EUDAMED registration mandatory. |
| Malta | MCCAA | Self-declaration | Notified Body review | Notified Body review | — | EU MDR applies. Notification fee €15/device/year. |
| Serbia | ALIMS | CE mark reliance | CE mark reliance | CE mark reliance | — | Fee tiered by product count. |
| Bosnia & Herzeg. | ALMBiH | CE mark reliance | CE mark reliance | CE mark reliance | — | CE marking accepted; national registration required. |
| Albania | AKBPM | CE mark required | CE mark required | CE mark required | — | CE marking required for market access. |
| North Macedonia | MALMED | CE mark required | CE mark required | CE mark required | — | Contact MALMED for current fee schedule. |
| Ukraine | MOH Ukraine | 30–90d | 30–90d | 60–180d | — | National registration required. EC/WHO GMP certificate accepted. |
| Belarus | RCEZ | 30–60d | 30–60d | 60–90d | — | EEU (EAEU) regulations apply. |
| Russia | Roszdravnadzor | 90d | 90d | 120d | — | EEU (EAEU) registration applies to whole customs union. |
| Georgia | NAPR | 30d | 60d | 90d | — | Contact NAPR for current fee schedule. |
| Armenia | SCEC | 30d | 60d | 90d | — | EEU (EAEU) regulations apply. |
| Azerbaijan | MHIA | 30d | 60d | 90d | — | Contact MHIA for current fee schedule. |
| Moldova | AMNSP | 30d | 60d | 90d | — | Contact AMNSP for current fee schedule. |
| Country | Authority | Class I/II (Small) | Class I/II (Large) | Class III/IV | Renewal Fee | Special Considerations |
|---|---|---|---|---|---|---|
| United Kingdom | MHRA | £500 (initial notif.) | Notified Body fees (private) | Notified Body fees (private) | Per MHRA schedule | UKCA marking required. |
| Germany | BfArM | No fee (Class I) | Notified Body fees (private) | Notified Body fees (private) | No fixed renewal | EU MDR Notified Body fees vary widely. |
| France | ANSM | No fee (Class I) | Notified Body fees (private) | Notified Body fees (private) | No fixed renewal | EU MDR applies. |
| Spain | AEMPS | No fee (Class I) | Notified Body fees (private) | Notified Body fees (private) | No fixed renewal | EU MDR applies. |
| Netherlands | CIBG / IGJ | No fee (Class I) | Notified Body fees (private) | Notified Body fees (private) | No fixed renewal | EU MDR applies. |
| Belgium | FAMHP | No fee (Class I) | Notified Body fees (private) | Notified Body fees (private) | No fixed renewal | Clinical trial: €12,847 (Class I–II). |
| Austria | BASG | No fee (Class I) | Notified Body fees (private) | Notified Body fees (private) | No fixed renewal | Small-company exemption available. |
| Switzerland | Swissmedic | CHF 500 (CHRN) | Notified Body fees (private) | Notified Body fees (private) | Annual CHRN fee | Aligned with EU MDR. |
| Sweden | MPA | No fee (Class I) | Notified Body fees (private) | Notified Body fees (private) | No fixed renewal | Clinical trial fee charged separately. |
| Finland | Fimea | No fee (Class I) | Notified Body fees (private) | Notified Body fees (private) | No fixed renewal | Inspection fee for AR/importers. |
| Ireland | HPRA | No fee (Class I) | Notified Body fees (private) | Notified Body fees (private) | No fixed renewal | EU MDR applies. |
| Iceland | Lyfjastofnun | No fee (Class I) | Notified Body fees (private) | Notified Body fees (private) | No fixed renewal | EEA member. |
| Portugal | INFARMED | 0.4% monthly sales | Notified Body fees (private) | Notified Body fees (private) | Annual levy | Via SRCT Portal. |
| Greece | EOF | €60–€600 (tiered) | Notified Body fees (private) | Notified Body fees (private) | €30–€300/yr | Class I fee tiered by product count. |
| Romania | ANMDMR | RON 1,446 (FSC 1–10 items) | Notified Body fees (private) | Notified Body fees (private) | Per decree | EU MDR applies. |
| Slovakia | ŠÚKL | Free (Class I notif.) | €845 (tech-doc) | €845 (tech-doc) | No fixed renewal | EU MDR applies. |
| Estonia | SAM | Per SAM decree | Notified Body fees (private) | Notified Body fees (private) | Per SAM decree | EU MDR applies. |
| Latvia | ZVA | Annual vigilance fee | Notified Body fees (private) | Notified Body fees (private) | Annual fee | EU MDR applies. |
| Croatia | HALMED | No fee (Class I) | Notified Body fees (private) | Notified Body fees (private) | No fixed renewal | EU MDR applies. |
| Malta | MCCAA | €15/device/year | Notified Body fees (private) | Notified Body fees (private) | €15/device/year | EU MDR applies. |
| Serbia | ALIMS | RSD 5,000–50,000 | RSD 5,000–50,000 | RSD 5,000–50,000 | 5-yr renewal | Fee tiered by product count. |
| Bosnia & Herzeg. | ALMBiH | — | — | — | 5-yr renewal | Contact ALMBiH for current fee schedule. |
| Albania | AKBPM | — | — | — | 5-yr renewal | Contact AKBPM for current fee schedule. |
| North Macedonia | MALMED | — | — | — | 5-yr renewal | Contact MALMED for current fee schedule. |
| Ukraine | MOH Ukraine | UAH 1,500–8,000 | UAH 1,500–8,000 | UAH 4,000–20,000 | 5-yr renewal | National registration required. |
| Belarus | RCEZ | BYN 200–1,000 | BYN 200–1,000 | BYN 500–2,000 | 5-yr renewal | EEU regulations apply. |
| Russia | Roszdravnadzor | RUB 5,000–30,000 | RUB 5,000–30,000 | RUB 10,000–50,000 | No fixed renewal | EEU registration; covers all customs union. |
| Georgia | NAPR | GEL 500–2,000 | GEL 500–2,000 | GEL 1,000–5,000 | 5-yr renewal | Contact NAPR for current fee schedule. |
| Armenia | SCEC | AMD 50,000–200,000 | AMD 50,000–200,000 | AMD 100,000–500,000 | 5-yr renewal | EEU regulations apply. |
| Azerbaijan | MHIA | AZN 50–500 | AZN 50–500 | AZN 100–1,000 | 5-yr renewal | Contact MHIA for current fee schedule. |
| Moldova | AMNSP | MDL 500–3,000 | MDL 500–3,000 | MDL 1,000–8,000 | 5-yr renewal | Contact AMNSP for current fee schedule. |
| Country | Authority | Establishment / GMP License Fee |
|---|---|---|
| United Kingdom | MHRA | MHRA establishment fee: £500–£1,500/yr |
| Germany | BfArM | No separate GMP fee under EU MDR |
| France | ANSM | No separate GMP fee under EU MDR |
| Spain | AEMPS | No separate GMP fee under EU MDR |
| Netherlands | CIBG / IGJ | No separate GMP fee under EU MDR |
| Belgium | FAMHP | No separate GMP fee under EU MDR |
| Austria | BASG | No separate GMP fee under EU MDR |
| Switzerland | Swissmedic | Inspection: CHF 3,000–15,000 |
| Sweden | MPA | No separate GMP fee under EU MDR |
| Finland | Fimea | Inspection fee charged separately |
| Ireland | HPRA | No separate GMP fee under EU MDR |
| Iceland | Lyfjastofnun | No separate GMP fee |
| Portugal | INFARMED | No separate GMP fee under EU MDR |
| Greece | EOF | No separate GMP fee under EU MDR |
| Romania | ANMDMR | Contact authority |
| Slovakia | ŠÚKL | Contact authority |
| Estonia | SAM | Contact authority |
| Latvia | ZVA | Contact authority |
| Croatia | HALMED | No separate GMP fee under EU MDR |
| Malta | MCCAA | No separate GMP fee under EU MDR |
| Serbia | ALIMS | Contact ALIMS |
| Bosnia & Herzeg. | ALMBiH | Contact authority |
| Albania | AKBPM | Contact authority |
| North Macedonia | MALMED | Contact authority |
| Ukraine | MOH Ukraine | Contact authority |
| Belarus | RCEZ | Contact authority |
| Russia | Roszdravnadzor | GMP inspection: RUB 30,000–200,000 |
| Georgia | NAPR | Contact authority |
| Armenia | SCEC | Contact authority |
| Azerbaijan | MHIA | Contact authority |
| Moldova | AMNSP | Contact authority |
| Country | Authority | Class I | Class II | Class III | Class IV | Special Considerations |
|---|---|---|---|---|---|---|
| Japan | PMDA | Class I: notification | Class II: 12 months | Class III: 12–24 months | Class IV: 24–36 months | Shonin/Ninsho pathways. Foreign accredited auditor (QMS) required. |
| China | NMPA | Class I: 30d | Class II: 60d | Class III: 180d | — | Domestic agent mandatory. Novel Class III: local clinical trial required. |
| India | CDSCO | Class A: 45d | Class B: 45d | Class C/D: 180d | — | Import license required. Clinical trial requirement for Class C/D. |
| South Korea | MFDS | Class I: 30d | Class II: 60d | Class III: 90d | — | GMP inspection required. KGMP certificate needed. |
| Australia | TGA | Class I: listing | Class IIa: 60d | Class III: 180d | — | ARTG listing/registration system. MDSAP accepted. |
| New Zealand | Medsafe | Class I–IIa: listing | Class IIb–III: 90d | Class III: 180d | — | No government fees for product registration. |
| Singapore | HSA | Class A: 30d | Class B: 90d | Class C: 180d | Class D: 300d | Class A exempt if low-risk. |
| Taiwan | TFDA | Class I: 30d | Class II: 60d | Class III: 90d | — | Local authorized agent mandatory. |
| Thailand | FDA | Class I: 30d | Class II: 60d | Class III: 90d | — | GMP inspection required for Class II–III. |
| Malaysia | MDA | Class A: 30d | Class B: 60d | Class C: 90d | Class D: 120d | ASEAN harmonized classification. |
| Indonesia | BPOM | Class A: 30d | Class B: 90d | Class C: 120d | Class D: 120d | Local importer/distributor required. |
| Hong Kong | MDCO | No pre-market approval | No pre-market approval | No pre-market approval | — | Voluntary notification; no mandatory registration as of 2026. |
| Pakistan | DRAP | Class A: 60d | Class B: 90d | Class C/D: 180d | — | Contact DRAP for current fee schedule. |
| Bangladesh | DGDA | — | — | — | — | Contact DGDA for current fee schedule. |
| Sri Lanka | NMRA | 30d | 60d | 90d | — | Contact NMRA for current fee schedule. |
| Cambodia | DDF | — | — | — | — | Contact DDF for current fee schedule. |
| Laos | FDDPI | — | — | — | — | Contact FDDPI for current fee schedule. |
| Vietnam | DAV | 30d | 60d | 90d | — | Contact DAV for current fee schedule. |
| Kazakhstan | RK MoH | 30d | 60d | 90d | — | EEU (EAEU) regulations apply. |
| Kyrgyzstan | SDFV | 30d | 60d | 90d | — | EEU (EAEU) regulations apply. |
| Uzbekistan | UzFDA | 30d | 60d | 90d | — | Contact UzFDA for current fee schedule. |
| Afghanistan | NMPAA | — | — | — | — | Contact NMPAA for current fee schedule. |
| Country | Authority | Class I/II (Small) | Class I/II (Large) | Class III/IV | Renewal Fee | Special Considerations |
|---|---|---|---|---|---|---|
| Japan | PMDA | JPY 5,560 (Class I notif.) | JPY 250,000–500,000 | JPY 500,000–2,000,000 | 5-yr renewal | Shonin/Ninsho pathway fees vary by device. |
| China | NMPA | CNY 900–3,000 (Class I) | CNY 5,000–15,000 | CNY 15,000–50,000 | 5-yr renewal | Novel Class III: additional clinical cost. |
| India | CDSCO | INR 2,000–50,000 | INR 2,000–50,000 | INR 50,000–200,000 | 5-yr renewal | Import license fee separate. |
| South Korea | MFDS | KRW 100,000–300,000 | KRW 300,000–1,000,000 | KRW 1,000,000–3,000,000 | 5-yr renewal | KGMP inspection fee separate. |
| Australia | TGA | AUD 100–500 (listing) | AUD 3,000–8,000 | AUD 5,000–20,000 | Annual TGA levy | MDSAP accepted; audit fee separate. |
| New Zealand | Medsafe | No fee (listing) | No fee | No fee | No fee | No government registration fees. |
| Singapore | HSA | SGD 500–1,000 (Class B) | SGD 1,000–2,000 | SGD 2,000–5,000 | 5-yr renewal | Class A exempt from fees. |
| Taiwan | TFDA | TWD 2,000–5,000 | TWD 5,000–15,000 | TWD 15,000–50,000 | 5-yr renewal | Local authorized agent mandatory. |
| Thailand | FDA | THB 5,000–20,000 | THB 10,000–40,000 | THB 20,000–100,000 | 5-yr renewal | GMP inspection fee separate. |
| Malaysia | MDA | MYR 500–1,500 | MYR 1,500–5,000 | MYR 3,000–10,000 | 5-yr renewal | ASEAN MDD harmonization. |
| Indonesia | BPOM | IDR 1,000,000–5,000,000 | IDR 5,000,000–10,000,000 | IDR 10,000,000–30,000,000 | 5-yr renewal | Local importer/distributor required. |
| Hong Kong | MDCO | — | — | — | No renewal fee | Voluntary notification; no mandatory fees. |
| Pakistan | DRAP | PKR 5,000–20,000 | PKR 10,000–50,000 | PKR 20,000–100,000 | 5-yr renewal | Contact DRAP for current fee schedule. |
| Bangladesh | DGDA | — | — | — | 5-yr renewal | Contact DGDA for current fee schedule. |
| Sri Lanka | NMRA | LKR 5,000–20,000 | LKR 10,000–50,000 | LKR 20,000–100,000 | 5-yr renewal | Contact NMRA for current fee schedule. |
| Cambodia | DDF | — | — | — | 5-yr renewal | Contact DDF for current fee schedule. |
| Laos | FDDPI | — | — | — | 5-yr renewal | Contact FDDPI for current fee schedule. |
| Vietnam | DAV | VND 5,000,000–15,000,000 | VND 5,000,000–15,000,000 | VND 15,000,000–50,000,000 | 5-yr renewal | Contact DAV for current fee schedule. |
| Kazakhstan | RK MoH | KZT 20,000–100,000 | KZT 20,000–100,000 | KZT 100,000–500,000 | 5-yr renewal | EEU regulations apply. |
| Kyrgyzstan | SDFV | KGS 2,000–10,000 | KGS 2,000–10,000 | KGS 10,000–50,000 | 5-yr renewal | EEU regulations apply. |
| Uzbekistan | UzFDA | UZS 500,000–2,000,000 | UZS 500,000–2,000,000 | UZS 2,000,000–10,000,000 | 5-yr renewal | Contact UzFDA for current fee schedule. |
| Afghanistan | NMPAA | — | — | — | Not published | Contact NMPAA for current fee schedule. |
| Country | Authority | Establishment / GMP License Fee |
|---|---|---|
| Japan | PMDA | QMS audit (accredited auditor): JPY 200,000–1,000,000 |
| China | NMPA | GMP inspection: CNY 20,000–100,000 |
| India | CDSCO | Manufacturing license fee varies by state; Site Master File required |
| South Korea | MFDS | KGMP inspection: KRW 300,000–2,000,000 |
| Australia | TGA | TGA manufacturing audit: AUD 3,000–15,000 |
| New Zealand | Medsafe | No GMP fee for importers |
| Singapore | HSA | HSA GMP audit: SGD 2,000–10,000 |
| Taiwan | TFDA | QSD audit fee: TWD 10,000–50,000 |
| Thailand | FDA | GMP inspection fee (foreign): contact FDA Thailand |
| Malaysia | MDA | GMP audit: MYR 2,000–10,000 |
| Indonesia | BPOM | GMP certificate: IDR 5,000,000–20,000,000 |
| Hong Kong | MDCO | No GMP requirement for importers |
| Pakistan | DRAP | Contact DRAP |
| Bangladesh | DGDA | Contact DGDA |
| Sri Lanka | NMRA | Contact NMRA |
| Cambodia | DDF | Contact DDF |
| Laos | FDDPI | Contact FDDPI |
| Vietnam | DAV | Contact DAV |
| Kazakhstan | RK MoH | Contact authority |
| Kyrgyzstan | SDFV | Contact authority |
| Uzbekistan | UzFDA | Contact authority |
| Afghanistan | NMPAA | Contact authority |
| Country | Authority | Class I | Class II | Class III | Class IV | Special Considerations |
|---|---|---|---|---|---|---|
| Saudi Arabia | SFDA | Class A: 30d | Class B: 90d | Class C: 180d | Class D: 180d | SFDA online portal. SFDAe-License for establishment. |
| UAE | MOHAP / DCCU | Class A: 30d | Class B: 60d | Class C: 90d | — | Local authorized agent mandatory. Dubai/Abu Dhabi separate authorities. |
| Egypt | EGMA | 30d | 60d | 90d | — | Contact EGMA for current fee schedule. |
| Oman | MOLA | 30d | 60d | 90d | — | Gulf-GCC mutual recognition available. |
| Qatar | MOPH | 30d | 60d | 90d | — | Gulf-GCC mutual recognition available. |
| Bahrain | NHRA | 30d | 60d | 90d | — | Streamlined; Gulf-GCC mutual recognition available. |
| Jordan | JFDA | 30d | 60d | 90d | — | Free Trade Agreement pathway with FDA. |
| Israel | MOH (MDR) | 30d | 60d | 90d | — | Reliance on FDA/EU decisions available. |
| Kuwait | MOH | 30d | 60d | 90d | — | Gulf-GCC mutual recognition available. |
| Lebanon | MOPH (LB) | 30d | 60d | 90d | — | Contact MOPH for current fee schedule. |
| Turkey | TITCK | 30d | 60d | 90d | — | TURKTRADE national database registration required. |
| Iran | No data available | |||||
| Iraq | No data available | |||||
| Morocco | DPMED | 30d | 60d | 90d | — | Contact DPMED for current fee schedule. |
| Tunisia | LNCM | 30d | 60d | 90d | — | Contact LNCM for current fee schedule. |
| Algeria | ANDPPM | 30d | 60d | 90d | — | Contact ANDPPM for current fee schedule. |
| Nigeria | NAFDAC | 30d | 60d | 90d | — | WHO CRP pathway available. |
| Kenya | PPB | 30d | 60d | 90d | — | WHO CRP pathway available. |
| Ethiopia | EFMHACA | 30d | 60d | 90d | — | Contact EFMHACA for current fee schedule. |
| Tanzania | TFDA | 30d | 60d | 90d | — | Contact TFDA for current fee schedule. |
| South Africa | SAHPRA | Class A: 60d | Class B: 90d | Class C: 180d | Class D: 180d | General sale to Class D. Risk-based classification. |
| Mauritius | MOH | 30d | 60d | 90d | — | Contact MOH for current fee schedule. |
| Yemen | GOPA | — | — | — | — | Contact GOPA for current fee schedule. |
| Syria | No data available | |||||
| Sudan | No data available | |||||
| Rwanda | RNDA | 30d | 60d | 90d | — | Contact RNDA for current fee schedule. |
| Madagascar | No data available | |||||
| Botswana | BOMRA | 30d | 60d | 90d | — | WHO CRP pathway available. |
| Country | Authority | Class I/II (Small) | Class I/II (Large) | Class III/IV | Renewal Fee | Special Considerations |
|---|---|---|---|---|---|---|
| Saudi Arabia | SFDA | SAR 500–2,000 | SAR 2,000–5,000 | SAR 5,000–15,000 | 5-yr renewal | SFDAe-License establishment fee: SAR 1,000–5,000. |
| UAE | MOHAP / DCCU | AED 1,000–3,000 | AED 3,000–8,000 | AED 5,000–20,000 | 5-yr renewal | Local authorized agent mandatory. |
| Egypt | EGMA | EGP 5,000–20,000 | EGP 10,000–50,000 | EGP 20,000–100,000 | 5-yr renewal | Contact EGMA for current fee schedule. |
| Oman | MOLA | OMR 100–500 | OMR 200–1,000 | OMR 500–2,000 | 5-yr renewal | Contact MOLA for current fee schedule. |
| Qatar | MOPH | QAR 500–2,000 | QAR 1,000–5,000 | QAR 2,000–10,000 | 5-yr renewal | Contact MOPH for current fee schedule. |
| Bahrain | NHRA | BHD 50–200 | BHD 100–500 | BHD 200–1,000 | 5-yr renewal | Streamlined fee structure. |
| Jordan | JFDA | JOD 50–200 | JOD 100–500 | JOD 200–1,000 | 5-yr renewal | FDA reliance pathway available. |
| Israel | MOH (MDR) | ILS 500–2,000 | ILS 1,000–5,000 | ILS 2,000–10,000 | 5-yr renewal | Reliance on FDA/EU available. |
| Kuwait | MOH | KWD 50–200 | KWD 100–500 | KWD 200–1,000 | 5-yr renewal | Contact MOH for current fee schedule. |
| Lebanon | MOPH (LB) | LBP 2,000,000–10,000,000 | LBP 5,000,000–20,000,000 | LBP 10,000,000–50,000,000 | 5-yr renewal | Contact MOPH for current fee schedule. |
| Turkey | TITCK | TRY 500–2,000 | TRY 1,000–5,000 | TRY 2,000–10,000 | 5-yr renewal | TURKTRADE database registration required. |
| Iran | No data available | |||||
| Iraq | No data available | |||||
| Morocco | DPMED | MAD 1,000–5,000 | MAD 2,000–10,000 | MAD 5,000–20,000 | 5-yr renewal | Contact DPMED for current fee schedule. |
| Tunisia | LNCM | TND 200–1,000 | TND 500–3,000 | TND 1,000–5,000 | 5-yr renewal | Contact LNCM for current fee schedule. |
| Algeria | ANDPPM | DZD 5,000–20,000 | DZD 10,000–50,000 | DZD 20,000–100,000 | 5-yr renewal | Contact ANDPPM for current fee schedule. |
| Nigeria | NAFDAC | NGN 50,000–200,000 | NGN 100,000–500,000 | NGN 200,000–1,000,000 | 5-yr renewal | WHO CRP pathway available. |
| Kenya | PPB | KES 5,000–20,000 | KES 10,000–50,000 | KES 20,000–100,000 | 5-yr renewal | WHO CRP pathway available. |
| Ethiopia | EFMHACA | ETB 5,000–20,000 | ETB 10,000–50,000 | ETB 20,000–100,000 | 5-yr renewal | Contact EFMHACA for current fee schedule. |
| Tanzania | TFDA | TZS 100,000–500,000 | TZS 200,000–1,000,000 | TZS 500,000–2,000,000 | 5-yr renewal | Contact TFDA for current fee schedule. |
| South Africa | SAHPRA | ZAR 500–2,000 | ZAR 2,000–8,000 | ZAR 5,000–20,000 | 5-yr renewal | Risk-based classification (General/Class A–D). |
| Mauritius | MOH | MUR 5,000–20,000 | MUR 10,000–50,000 | MUR 20,000–100,000 | 5-yr renewal | Contact MOH for current fee schedule. |
| Yemen | GOPA | — | — | — | Not published | Contact GOPA for current fee schedule. |
| Syria | No data available | |||||
| Sudan | No data available | |||||
| Rwanda | RNDA | RWF 50,000–200,000 | RWF 100,000–500,000 | RWF 200,000–1,000,000 | 5-yr renewal | Contact RNDA for current fee schedule. |
| Madagascar | No data available | |||||
| Botswana | BOMRA | BWP 500–2,000 | BWP 1,000–5,000 | BWP 2,000–10,000 | 5-yr renewal | WHO CRP pathway available. |
| Country | Authority | Establishment / GMP License Fee |
|---|---|---|
| Saudi Arabia | SFDA | SFDA GMP inspection: SAR 5,000–20,000 |
| UAE | MOHAP / DCCU | GMP certificate required; inspection: AED 5,000–20,000 |
| Egypt | EGMA | GMP inspection fee: contact EGMA |
| Oman | MOLA | Contact MOLA |
| Qatar | MOPH | Contact MOPH |
| Bahrain | NHRA | Contact NHRA |
| Jordan | JFDA | Contact JFDA |
| Israel | MOH (MDR) | Contact MOH |
| Kuwait | MOH | Contact MOH |
| Lebanon | MOPH (LB) | Contact MOPH |
| Turkey | TITCK | GMP inspection: TRY 5,000–30,000 |
| Iran | No data available | |
| Iraq | No data available | |
| Morocco | DPMED | Contact DPMED |
| Tunisia | LNCM | Contact LNCM |
| Algeria | ANDPPM | Contact ANDPPM |
| Nigeria | NAFDAC | NAFDAC facility inspection: NGN 50,000–200,000 |
| Kenya | PPB | Contact PPB |
| Ethiopia | EFMHACA | Contact EFMHACA |
| Tanzania | TFDA | Contact TFDA |
| South Africa | SAHPRA | SAHPRA GMP inspection: ZAR 10,000–50,000 |
| Mauritius | MOH | Contact MOH |
| Yemen | GOPA | Contact GOPA |
| Syria | No data available | |
| Sudan | No data available | |
| Rwanda | RNDA | Contact RNDA |
| Madagascar | No data available | |
| Botswana | BOMRA | Contact BOMRA |